⌘K
Loading ticker…
As of 2026-08-24, Northrop Grumman Corp. (NOC) has a 3-month relative strength percentile of 45 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.4%, relative volume 0.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
NOC is in a stage 1 base, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 1.3% / -9.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
NOC appears in 1 ETF as of Jun 2026: PY at 0.72% weight, $2M notional.
Held by 291 ETFs · $15.3B across latest filings · largest weight 5.79% (GCAD).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PY | 0.72% | $2M | −0.30 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NOC Jan avg: 0.70% median: -0.37% win: 50% σ: 16.45% n: 4 2022-04-12 → 2026-07-31 | NOC Feb avg: 1.54% median: 3.39% win: 75% σ: 4.56% n: 4 2022-04-12 → 2026-07-31 | NOC Mar avg: 2.10% median: 1.66% win: 50% σ: 7.06% n: 4 2022-04-12 → 2026-07-31 | NOC Apr avg: -4.75% median: -4.92% win: 20% σ: 6.42% n: 5 2022-04-12 → 2026-07-31 | NOC May avg: -1.85% median: -2.73% win: 20% σ: 5.34% n: 5 2022-04-12 → 2026-07-31 | NOC Jun avg: -0.57% median: 2.27% win: 60% σ: 5.89% n: 5 2022-04-12 → 2026-07-31 | NOC Jul avg: 6.13% median: 6.51% win: 80% σ: 7.39% n: 5 2022-04-12 → 2026-07-31 | NOC Aug avg: 1.87% median: 1.07% win: 50% σ: 4.58% n: 4 2022-04-12 → 2026-07-31 (current) | NOC Sep avg: 1.06% median: 1.28% win: 75% σ: 2.03% n: 4 2022-04-12 → 2026-07-31 | NOC Oct avg: 3.99% median: 1.75% win: 50% σ: 9.96% n: 4 2022-04-12 → 2026-07-31 | NOC Nov avg: -1.95% median: -2.39% win: 25% σ: 1.98% n: 4 2022-04-12 → 2026-07-31 | NOC Dec avg: -0.92% median: -0.92% win: 25% σ: 2.68% n: 4 2022-04-12 → 2026-07-31 |